Microba is pleased to share its results for the first half of the 2024 Financial Year. See here for the full report: https://t.co/sI20K9kcvb

Microba is proud to be sponsoring Monash University’s #GINSymposium2024. Stop by the Microba exhibition to learn how our end-to-end expertise in microbiome analysis can help you accelerate your microbiome research with clear data for decisive outcomes. https://t.co/apngwUhVZ5

#OCTWestCoast starts tomorrow - meet with Dr Kylie Ellis, Head of Research Partnerships at the Microba stand, and discover the insights that come from including quality microbiome data in your clinical trial, https://t.co/ZIKLqFoTZw #ClinicalTrials #Outsourcing #healthcare

Microba will be at the upcoming #Probiota 2024, February 7-9. If you’re looking to fast-track your probiotic and LBP discovery and testing program, connect with Mark Parker, Global Business Development. Contact: mark.parker@microba.com #probiotics #microbiome #innovation #LBPs

Stop by the Microba stand at #OCTWestCoast, 6-7 February and chat with Dr Kylie Ellis, Head of Research Partnerships and learn how Microba can deliver clear #microbiome measurement and interpretation for your clinical trials program. https://t.co/ZIKLqFoTZw #ClinicalTrials

Microba is pleased to provide a summary of its activities for the quarter ended 31 December 2023. See here for full coverage of the report: https://t.co/5O2YOVfs4H

Microba is looking forward to #JPM24 in San Francisco next week! Alongside the @QldGov and @Brisbane_EDA, we’re proud to represent Brisbane as a leading destination for technology and innovation in the health sector. #alivewithopportunity Learn more: https://t.co/BMDhx9c4zr

Microba is pleased to share that lead drug candidate, MAP 315, demonstrated it is safe and well tolerated at both low and high doses in the Phase 1, healthy volunteer clinical trial. Read the full announcement here: https://t.co/zyshbEDiPu

Microba’s Autoimmune disease program with synthetic biology leader @Ginkgo Bioworks reaches a key milestone; the completion of Stage 1 activity screening of lead strains. Read the full update here: https://t.co/XjlSB6Tspc

Join us at #AusBioInvest next Monday, @AusBiotech's premier event for #InvestInHealth and collaboration across life sciences and medical research. Prof @trent_munro, Microba Senior VP, Therapeutics will give a company presentation at 4pm AEDT. Register: https://t.co/PXxnRyzVoq

Tomorrow, join Dr Kylie Ellis, Head of Research Partnerships at the 11th #MicrobiomeForum for a talk on ‘Next-gen biotics: From data to delivery.’ Discover Microba’s biotic discovery process and how we help clients create effective biotic products: https://t.co/oJUXJRBGt5

Join us in San Diego next week at #MicrobiomeForum! Meet Dr. Kylie Ellis, our Head of Research Partnerships, and learn about our approach to biotic discovery for probiotics, LBPs, prebiotics, and synbiotics. Kylie will also give a presentation on Day 2 at 10:20 PST.

Our Discovery Platform lets you investigate complex microbiome relationships through a comprehensive cohort of analysed samples accompanied by health data. Discover the robust insights you can leverage from our comprehensive databank: https://t.co/4giBc6akiN

We see a world where human health is transformed by microbiome science. We work tirelessly to better understand the microbiome’s potential to positively impact human health and pioneer new health solutions that harness this deep understanding: https://t.co/gvsgkn7qoX

A/Prof Krause will outline the application of precision microbiome science for the development of novel products for improving human health, with a specific focus given to microbiome-derived therapeutics. Learn more about our therapeutic approach here:

The @Illumina Population Genomics Summit starts today in Singapore and Microba is pleased to support the Summit’s activities. Tomorrow, A/Prof Lutz Krause, Microba Chief Scientific Officer will present at 3:45 pm.

Our advanced metagenomic analysis is combined with the latest research on the microbiome's role in health to deliver a range of health solutions. Learn how we partner with organisations across the world to deliver market-leading microbiome testing: https://t.co/OB9m6cmgOe

Microba is proud to support @Illumina and the 2023 Population Genomics Summit in Singapore. A/Prof Lutz Krause, CSO will present on Wed 27 September; AI Guided, Large Cohort-Based Discovery of Live Biotherapeutics from the Human Gut. Register: https://t.co/dfCzuJFV3r

Microba has the expertise to help you develop differentiated and evidence-based microbiome-targeting products for various applications. Explore how you can confidently leverage our discovery expertise for 'biotic product development and testing: https://t.co/oJUXJRBGt5

Microba is happy to share a new article in partnership with @illumina. Follow the link to learn about common hurdles in the #tertiary #analysis of #metagenomics data and how you can overcome them to support robust scientific discoveries. Read article: https://t.co/giTtyRl5rj